Delivery Order SPE2DB22D1017-SPE2DB24FG4CH
Award Date
8/28/24
Potential Completion Date
8/29/24
Potential Value
$8.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $12,063.41 firm fixed-price delivery order to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of fluticasone-salmeterol 230-21 12GM, a combination medication used for the treatment of asthma and chronic obstructive pulmonary disease. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,939.44 firm fixed price delivery order is for the supply of fluticasone-salmeterol 115-21 12GM, a combination medication used for the treatment of asthma and COPD. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,475.42 contract is for the delivery of fluticasone-salmeterol 115-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of April 11, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $2,689.89 firm fixed-price contract is for the supply of fluticasone-salmeterol 230-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). This order is placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order, valued at $6,894.90, is for the procurement of fluticasone-salmeterol 230-21 12GM, a combination medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,364.06 firm fixed-price contract is for the supply of fluticasone-salmeterol 115-21 12GM, a respiratory medication, through January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of fluticasone-salmeterol 230-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract is a firm fixed-price delivery order with a ceiling value of $5,699.14 and a period of performance through May 8, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,272.81 firm fixed-price delivery order is for the supply of fluticasone-salmeterol 115-21 12GM, which is a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with...
This is a $1,147.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The award is not set-aside and has an ultimate completion date of July 16, 2025. AmerisourceBergen holds a significant $999,999,999.00...
This is a $5,414.15 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...